Allergy/Asthma News

BOSTON — Community engagement can help stock inhaler programs for underserved rural schools succeed, according to two posters presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

During assessments of episodic memory, processing speed, and inhibition and attention, children with vs. without asthma had poorer scores, according to results published in JAMA Network Open.

The FDA has accepted the resubmission of the supplemental biologics license application for Dupixent to treat chronic spontaneous urticaria in adults and children, Regeneron Pharmaceutical and Sanofi announced in a press release.

Upadacitinib exhibited efficacy and a favorable benefit-risk profile for the long-term treatment of moderate to severe atopic dermatitis in adolescents, according to a study.

BOSTON — There is a need for more education in recognizing anaphylaxis among patients with allergies, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Macrolides likely reduce severe exacerbations and improve quality of life and asthma control among patients with asthma, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

IgGenix announced the first patient dosed with IGNX001, a monoclonal antibody-based therapeutic for peanut allergy.

Why not just invest in one stock and let it ride? That works well if you bet the farm on Apple in 2010 and watched your fortune explode 30 time during the last 14 years.

Priya J. Bansal, MD, FAAAAI, FACAAI, has always prioritized quality patient care as an allergist, but as insurance companies create more barriers for patients, Bansal has been advocating for policies to return to a quality-of-care model.

BOSTON — Vaccine hesitancy was less likely to occur in racially diverse vs. white patients, although this hesitancy was not significantly impacted by age, sex or language, according to a poster presentation here.